Company intelligence / Profile preview

Elincou Diagnostics

Latsia, Nicosia District, Cypruselincou.com ↗

Ownership: Private
Development stage: Commercial

Overview

Elincou Diagnostics provides in-vitro diagnostic devices, scientific equipment, software solutions, consumables for blood sugar self-testing devices, and laboratory analysis services. The company serves both public sector clinical laboratories and private clinics/hospitals. No clinical trial results are reported as it does not develop therapeutics.

Modalities: DeviceSoftwareConsumables
Industry: Metabolite Diagnostics

Drug pipeline

1 asset

GenSure COVID-19 Antigen Rapid Test Kit

Commercial

Indications: COVID-19

Partnerships

The company lists various partners for manufacturing high-quality products but does not specify major pharmaceutical/biotech partnerships by name.

Beyond the preview

Go deeper on Elincou Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elincou Diagnostics.

Explore the full profile